Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Cancer Sci ; 106(10): 1278-87, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26183471

ABSTRACT

Cancer-associated fibroblasts (CAFs), as the activated fibroblasts in the tumor stroma, are important modifiers of tumour progression. In the present study, we observed that azoxymethane and dextran sodium sulfate treatments induced increasingly severe colorectal mucosal inflammation and the intratumoural accumulation of CAFs. Fibroblast growth factor (FGF)-1 and FGF-3 were detected in infiltrating cells, and FGFR4, the specific receptor for FGF-1 and FGF-3, was detected in colon cancer tissues. The phosphorylation of FGFR4 enhanced the production of metalloproteinase (MMP)-7 and mitogen-activated protein kinase kinase (Mek)/extracellular signal-regulated kinase (Erk), which was accompanied by excessive vessel generation and cell proliferation. Moreover, we separated CAFs, pericarcinoma fibroblasts (PFs), and normal fibroblasts (NFs) from human colon tissue specimens to characterize the function of CAFs. We observed that CAFs secrete more FGF-1/-3 than NFs and PFs and promote cancer cell growth and angiogenesis through the activation of FGFR4, which is followed by the activation of Mek/Erk and the modulation of MMP-7 expression. The administration of FGF-1/-3-neutralizing antibodies or the treatment of cells with FGFR4 siRNA or the FGFR4 inhibitor PD173074 markedly suppressed colon cancer cell proliferation and neovascularization. These observations suggest a crucial role for CAFs and FGF signaling in the initiation and progression of colorectal cancer. The inhibition of the FGF signaling pathway may be a useful strategy for the treatment of colon cancer.


Subject(s)
Colitis, Ulcerative/pathology , Colonic Neoplasms/pathology , Extracellular Signal-Regulated MAP Kinases/metabolism , Fibroblast Growth Factor 1/metabolism , Fibroblast Growth Factor 3/metabolism , Matrix Metalloproteinase 7/metabolism , Receptor, Fibroblast Growth Factor, Type 4/metabolism , Animals , Azoxymethane , Cell Line, Tumor , Colitis, Ulcerative/metabolism , Colonic Neoplasms/genetics , Dextran Sulfate , Disease Models, Animal , Disease Progression , Fibroblast Growth Factor 3/pharmacology , Fibroblasts/metabolism , HCT116 Cells , HT29 Cells , Human Umbilical Vein Endothelial Cells , Humans , MAP Kinase Signaling System/genetics , Mice , Phosphorylation , Pyrimidines/pharmacology , RNA Interference , RNA, Small Interfering , Receptor Protein-Tyrosine Kinases/antagonists & inhibitors , Receptor, Fibroblast Growth Factor, Type 4/antagonists & inhibitors , Receptor, Fibroblast Growth Factor, Type 4/genetics , Receptors, Fibroblast Growth Factor/antagonists & inhibitors
2.
PLoS One ; 7(12): e51848, 2012.
Article in English | MEDLINE | ID: mdl-23272179

ABSTRACT

Ulcerative colitis (UC) is a major form of chronic inflammation that can frequently progress to colon cancer. Several studies have demonstrated massive infiltration of neutrophils and macrophages into the lamina propria and submucosa in the progression of UC-associated colon carcinogenesis. Macrophages contribute to the development of colitis-associated colon cancer (CAC). However, the role of neutrophils is not well understood. To better understand the involvement of tumor-associated neutrophils (TANs) in the regulation of CAC, we used a mouse CAC model produced by administering azoxymethane (AOM), followed by repeated dextran sulfate sodium (DSS) ingestion. This causes severe colonic inflammation and subsequent development of multiple tumors in mice colon. We observed that colorectal mucosal inflammation became increasingly severe with AOM and DSS treatment. Macrophages infiltrated the lamina propria and submucosa, together with a marked increase in neutrophil infiltration. The chemokine CXCL2 increased in the lamina propria and submucosal regions of the colons of the treated mice, together with the infiltration of neutrophils expressing CXCR2, a specific receptor for CXCL2. This process was followed by neoplastic transformation. After AOM and DSS treatment, the mice showed enhanced production of metalloproteinase (MMP)-9 and neutrophil elastase (NE), accompanied by excessive vessel generation and cell proliferation. Moreover, CXCL2 promoted neutrophil recruitment and induced neutrophils to express MMP-9 and NE in vitro. Furthermore, administration of neutrophil-neutralizing antibodies after the last DSS cycle markedly reduced the number and size of tumors and decreased the expression of CXCR2, CXCL2, MMP-9, and NE. These observations indicate a crucial role for TANs in the initiation and progression of CAC and suggest that the CXCL2-CXCR2 axis might be useful in reducing the risk of UC-associated colon cancer.


Subject(s)
Cell Transformation, Neoplastic , Colitis/complications , Colitis/immunology , Colonic Neoplasms/etiology , Colonic Neoplasms/pathology , Neutrophils/immunology , Animals , Antibodies, Monoclonal/administration & dosage , Antibodies, Monoclonal/immunology , Antigens, Ly/immunology , Cell Proliferation , Cell Transformation, Neoplastic/immunology , Chemokine CXCL2/genetics , Chemokine CXCL2/metabolism , Chronic Disease , Colitis, Ulcerative/complications , Colitis, Ulcerative/immunology , Disease Models, Animal , Female , Gene Expression Regulation, Neoplastic , Leukocyte Elastase/genetics , Leukocyte Elastase/metabolism , Matrix Metalloproteinase 9/genetics , Matrix Metalloproteinase 9/metabolism , Mice , Neovascularization, Pathologic , Neutrophil Infiltration/immunology , Neutrophils/metabolism , Proliferating Cell Nuclear Antigen/genetics , Proliferating Cell Nuclear Antigen/metabolism , Receptors, Interleukin-8B/genetics , Receptors, Interleukin-8B/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...